APA (7th ed.) Citation

S, T., T, S., S, O., R, A., CG, C., S, L. F., . . . F, P. (2025). First-year treatment response predicts the following 5-year disease course in patients with relapsing-remitting multiple sclerosis. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 22(2), e00552. https://doi.org/10.1016/j.neurot.2025.e00552

Chicago Style (17th ed.) Citation

S, Toscano, et al. "First-year Treatment Response Predicts the Following 5-year Disease Course in Patients with Relapsing-remitting Multiple Sclerosis." Neurotherapeutics : The Journal of the American Society for Experimental NeuroTherapeutics 22, no. 2 (2025): e00552. https://doi.org/10.1016/j.neurot.2025.e00552.

MLA (9th ed.) Citation

S, Toscano, et al. "First-year Treatment Response Predicts the Following 5-year Disease Course in Patients with Relapsing-remitting Multiple Sclerosis." Neurotherapeutics : The Journal of the American Society for Experimental NeuroTherapeutics, vol. 22, no. 2, 2025, p. e00552, https://doi.org/10.1016/j.neurot.2025.e00552.